Lactate dehydrogenase level as a COVID-19 severity marker
Łukasz Szarpak(Uczelnia Warszawska im. Marii Skłodowskiej-Curie), Kurt Ruetzler(Cleveland Clinic), Kamil Safiejko(Medical University of Białystok), Michał Hampel(Central Clinical Hospital), Michał Pruc, Luiza Kanczuga - Koda(Medical University of Białystok), Krzysztof J. Filipiak(Medical University of Warsaw), Miłosz Jaguszewski(Gdańsk Medical University)
Cited by 109Open Access
Abstract
Related Papers
Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
Brandon Michael Henry, Maria Helena Santos de Oliveira, Stefanie W. Benoit et al.|Clinical Chemistry and Laboratory Medicine (CCLM)|2020|2k
Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis
Brandon Michael Henry, Gaurav Aggarwal, Johnny Wong et al.|The American Journal of Emergency Medicine|2020|633